1. Home
  2. LOMA vs ANL Comparison

LOMA vs ANL Comparison

Compare LOMA & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

LOMA

Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

HOLD

Current Price

$9.16

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$15.61

Market Cap

998.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOMA
ANL
Founded
1926
2004
Country
Argentina
Singapore
Employees
N/A
N/A
Industry
Building Materials
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
998.8M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
LOMA
ANL
Price
$9.16
$15.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
7
Target Price
$14.30
★ $29.50
AVG Volume (30 Days)
★ 308.4K
139.1K
Earning Date
11-05-2026
08-14-2026
Dividend Yield
★ 1.06%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.53
$243.83
Revenue Next Year
$10.89
N/A
P/E Ratio
$187.97
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.28
$0.88
52 Week High
$13.20
$17.25

Technical Indicators

Market Signals
Indicator
LOMA
ANL
Relative Strength Index (RSI) 31.01 56.23
Support Level N/A $12.45
Resistance Level $12.05 $17.25
Average True Range (ATR) 0.29 1.01
MACD -0.03 -0.07
Stochastic Oscillator 1.64 43.34

Price Performance

Historical Comparison
LOMA
ANL

About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS

Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The Group is engaged in the production and distribution of cement, masonry cement, concrete, limestone, and aggregates, operates a railway concession to provide transportation services, and is also engaged in the industrial waste recycling business. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

Share on Social Networks: